Recent aga clinical practice guideline acknowledges that individuals who may be at increased risk of progression to esophageal cancer might be identified using tissue-based biomarkers, particularly castle biosciences' tissuecypher® test

Friendswood, texas--(business wire)---- $cstl #aga--the latest aga clinical practice guideline acknowledges the role that tissuecypher can play identifying high-risk barrett's esophagus patients.

CSTL Ratings Summary

CSTL Quant Ranking